Contrasting Jin Medical International (NASDAQ:ZJYL) and Smith & Nephew (NYSE:SNN)

Jin Medical International (NASDAQ:ZJYL) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Risk & Volatility

Jin Medical International has a beta of 12.24, meaning that its stock price is 1,124% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Institutional & Insider Ownership

25.6% of Smith & Nephew shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Jin Medical International and Smith & Nephew’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Smith & Nephew	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Jin Medical International and Smith & Nephew, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	0	0	0	0	0.00
Smith & Nephew	0	6	0	0	2.00

Smith & Nephew has a consensus target price of $28.00, suggesting a potential downside of 1.19%. Given Smith & Nephew’s stronger consensus rating and higher possible upside, analysts plainly believe Smith & Nephew is more favorable than Jin Medical International.

Earnings and Valuation

This table compares Jin Medical International and Smith & Nephew”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$23.50 million	5.49	$3.68 million	N/A	N/A
Smith & Nephew	$5.81 billion	2.14	$263.00 million	$2.16	13.12

Smith & Nephew has higher revenue and earnings than Jin Medical International.

Summary

Smith & Nephew beats Jin Medical International on 6 of the 8 factors compared between the two stocks.

About Jin Medical International

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.